Imaging of nonmotor symptoms in Parkinson syndromes

被引:0
|
作者
Paulus, W
Trenkwalder, C
机构
[1] Univ Hosp Gottingen, Dept Clin Neurophysiol, Gottingen, Germany
[2] Univ Munich, Munich, Germany
关键词
Parkinson's disease; depression; neuropsychology; imaging; PET; SPECT;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuroimaging modalities in Parkinson's Disease (PD) are primarily used for the differential diagnosis of Parkinson syndromes and to understand pathophysiological mechanisms in PD. Neuroimaging of nonmotor dysfunctions in PD mostly consist of functional studies in neuropsychologically impaired PD patients using PET or SPECT techniques. Various studies controversially discuss the probable frontal versus temporal hypometabolism in demented PD patients. Functional studies of PD patients with depression are limited to case reports showing an involvement of left frontal regions. To investigate the pathophysiology of hallucinations with functional imaging may be a promising field of future research. Clinical Neuroscience 5:115-120, 1998. (C) 2000 Wiley-Liss. Inc.
引用
收藏
页码:115 / 120
页数:6
相关论文
共 50 条
  • [31] Emergence of Nonmotor Symptoms as the Focus of Research and Treatment of Parkinson's Disease: Introduction to the Special Section on Nonmotor Dysfunctions in Parkinson's Disease
    Cronin-Golomb, Alice
    BEHAVIORAL NEUROSCIENCE, 2013, 127 (02) : 135 - 138
  • [32] Nonmotor Symptoms in Parkinson's Disease in 2012: Relevant Clinical Aspects
    Bonnet, Anne Marie
    Jutras, Marie France
    Czernecki, Virginie
    Corvol, Jean Christophe
    Vidailhet, Marie
    PARKINSONS DISEASE, 2012, 2012
  • [33] Gender Differences of Nonmotor Symptoms Affecting Quality of Life in Parkinson Disease
    Yoon, Jee-Eun
    Kim, Ji Sun
    Jang, Wooyoung
    Park, Jinse
    Oh, Eungseok
    Youn, Jinyoung
    Park, Suyeon
    Cho, Jin Whan
    NEURODEGENERATIVE DISEASES, 2017, 17 (06) : 276 - 280
  • [34] Tolcapone addition improves Parkinson's disease associated nonmotor symptoms
    Mueller, Thomas
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2014, 7 (02) : 77 - 82
  • [35] Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's Disease
    Paracha, Mariam
    Herbst, Konnor
    Kieburtz, Karl
    Venuto, Charles S.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2022, 9 (07): : 961 - 966
  • [36] The Onset of Nonmotor Symptoms in Parkinson's Disease (The ONSET PD Study)
    Pont-Sunyer, Claustre
    Hotter, Anna
    Gaig, Carles
    Seppi, Klaus
    Compta, Yaroslau
    Katzenschlager, Regina
    Mas, Natalia
    Hofeneder, Dominik
    Bruecke, Thomas
    Bayes, Angels
    Wenzel, Karoline
    Infante, Jon
    Zach, Heidemarie
    Pirker, Walter
    Posada, Ignacio J.
    Alvarez, Ramiro
    Ispierto, Lourdes
    De Fabregues, Oriol
    Callen, Antoni
    Palasi, Antoni
    Aguilar, Miquel
    Jose Marti, Maria
    Valldeoriola, Francesc
    Salamero, Manel
    Poewe, Werner
    Tolosa, Eduardo
    MOVEMENT DISORDERS, 2015, 30 (02) : 229 - 237
  • [37] Noninvasive Brain Stimulation and Implications for Nonmotor Symptoms in Parkinson's Disease
    Rektorova, Irena
    Anderkova, L'ubomira
    NONMOTOR PARKINSON'S: THE HIDDEN FACE - MANAGEMENT AND THE HIDDEN FACE OF RELATED DISORDERS, 2017, 134 : 1091 - 1110
  • [38] Experiences of Living With the Nonmotor Symptoms of Parkinson's Disease: A Photovoice Study
    Smith, Laura J.
    Callis, Jerri
    Bridger-Smart, Shannon
    Guilfoyle, Olivia
    HEALTH EXPECTATIONS, 2024, 27 (03)
  • [39] The impact of deep brain stimulation on the nonmotor symptoms of Parkinson’s disease
    Keyoumars Ashkan
    Michael Samuel
    Prashanth Reddy
    K. Ray Chaudhuri
    Journal of Neural Transmission, 2013, 120 : 639 - 642
  • [40] Decreased Striatal Vesicular Monoamine Transporter Type 2 Correlates With the Nonmotor Symptoms in Parkinson Disease
    Shi, Xinchong
    Zhang, Yan
    Xu, Shaohua
    Kung, Hank F.
    Qiao, Hongwen
    Jiang, LuLu
    Zhu, Lin
    Guo, Qiyi
    Yi, Chang
    Luo, Ganhua
    Wu, Lei
    Pei, Zhong
    Wang, Jian
    Zhang, Xiangsong
    Chen, Ling
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 707 - 713